Release Date: 30/09/13 09:28 Summary: Appendix 3Y - Change of Director's Interest Notice Price Sensitive: No Download Document 170.67KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%